Holen Sie sich die Stockscreener-App
24.17
0.55%
0.1328
Amplify Weight Loss Drug Treatment Etf Aktie (THNR) Neueste Nachrichten
is medicare going to cover weight loss drugs in 2025 - BusinessWorld Online
From Laggard to Leader: The Surprising Comeback of Healthcare - ETF Trends
what weight loss drug is weight watchers using - BusinessWorld Online
sweeping review suggests effect of weight-loss drugs on 175 conditions - Olhar Digital
glp1 weight loss drug marketplace florida changes 2025 - BusinessWorld Online
new weight loss drug news - Olhar Digital
weight loss drug recently approved by fda - BusinessWorld Online
trump announces weight loss drug - BusinessWorld Online
will medicare cover weight loss drugs in 2026 for seniors - www2.polskieradio.pl
novo nordisk weight loss drug news - polskieradio.pl
Avoiding Lag: Real-Time Signals in (THNR) Movement - Stock Traders Daily
fda approves weight loss drug october 2025 - polskieradio.pl
weight loss drug news today november 24 2025 - Polskie Radio
ETFs with Merck & Co., Inc. ( MRK ) Exposure - etfdb.com
eli lillys new weight loss drug - www.polskieradio.pl
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win - The Globe and Mail
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win - Zacks Investment Research
Lilly vs. Novo: Inside the Milan EASD Showdown and the ETFs Poised to Win - TradingView
do glp1 pills work as well as injections - polskieradio.pl
the new weight-loss drug - polskieradio.pl
Who Are You Calling Passive? Many Index ETFs Dynamically Rebalanced in September - ETF Database
fda approved weight loss drugs 2026 latest - polskieradio.pl
(THNR) and the Role of Price-Sensitive Allocations - Stock Traders Daily
NTHM’s Index Rebalance Puts Thematic Rotation to Work - ETF Database
5 Best GLP-1 Stocks for 2026 and How to Invest - The Motley Fool
THNR's Weight-Loss Index Swaps Hims & Hers for Gilead - ETF Database
THNR's Weight-Loss Index Swaps Hims & Hers for Gilead - ETF Trends
How (THNR) Movements Inform Risk Allocation Models - Stock Traders Daily
ETFs Investing in Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class H Stocks - TradingView
(THNR) Risk Channels and Responsive Allocation - Stock Traders Daily
CSPC Pharma stock slips as China weight management trial begins - ad-hoc-news.de
(THNR) Price Dynamics and Execution-Aware Positioning - Stock Traders Daily
ETFs Investing in Novo Nordisk A/S Sponsored ADR Class B Stocks - TradingView
Eli Lilly and Co (LLY): The Shop Floor Investor's Journey and Analysis - Moomoo
(THNR) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
Pfizer Inc (PFE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
AstraZeneca PLC (AZN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Scholar Rock Holding Corp (SRRK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Regeneron Pharmaceuticals Inc (REGN) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Novo Nordisk A/S (NVO) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Hims & Hers Health Inc (HIMS) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Amgen Inc (AMGN) Shareholder Structure: Major Shareholders & Institutional Holdings - tradingkey.com
(THNR) Risk Channels and Responsive Allocation - Stock Traders Daily
ETFs Investing in Novo Nordisk A/S Sponsored ADR Class B Stocks - TradingView
THNR ETF Profile: Dividends, Returns (BOATS:THNR) - TradingView
THNR ETF Profile: Dividends, Returns (AMEX:THNR) - TradingView
(THNR) Risk Channels and Responsive Allocation - Stock Traders Daily
Weight loss drug market to hit $130-150B by 203... - Pluang
Inside THNR: A Leaner Approach to Weight Loss Investing - ETF Database
(THNR) Movement as an Input in Quant Signal Sets - Stock Traders Daily
0.71%
0.04%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):